Phase I study of patritumab deruxtecan (HER3-DXd) in patients (pts) with advanced KRAS G12C non-small cell lung cancer (NSCLC): Study U102 cohort 5 Meeting Abstract
| Authors: | Paz-Ares, L.; Steuer, C.; Ruiter, G.; Nishio, M.; Murakami, H.; Kim, D. W.; Felip, E.; Baik, C. S.; Lin, C. C.; Massarelli, E.; Ahn, M. J.; Su, X.; Fujimura, M.; Pasupuleti, L.; Aguilo, A.; Esker, S.; Yu, H. A.; Hayashi, H.; Jänne, P. A. |
| Abstract Title: | Phase I study of patritumab deruxtecan (HER3-DXd) in patients (pts) with advanced KRAS G12C non-small cell lung cancer (NSCLC): Study U102 cohort 5 |
| Meeting Title: | European Lung Cancer Congress (ELCC) 2025 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 20 |
| Issue: | 3 Suppl. 1 |
| Meeting Dates: | 2025 Mar 26-29 |
| Meeting Location: | Paris, France |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2025-03-01 |
| Start Page: | S88 |
| End Page: | S90 |
| DOI: | 10.1016/s1556-0864(25)00320-x |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 125TiP -- Source: Cinahl |
